Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited)

v3.22.2.2
Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Total
Balance - December 31, 2020 at Dec. 31, 2020 $ 2,537 $ 64 $ 87,570 $ (88,275) $ (2,369) $ (473)
Balance, shares at Dec. 31, 2020 1,228,075 63,819,935          
Series B Convertible Preferred Stock dividends declared $ 148 (148)
Series B convertible preferred stock dividends declared, shares 49,244            
Vest - restricted stock awards  
Vest - restricted stock awards, shares   150,000          
Exercise - stock options 131   131
Exercise - stock options, shares   120,832          
Stock-based compensation - PAVmed Inc. 3,254   3,254
Stock-based compensation - majority-owned subsidiary 56   3,329 3,385
Net Loss (20,902) (1,877) (22,779)
Issue common stock – exercise Series Z warrants $ 2 2,783   2,785
Issue common stock - exercise Series Z warrants, shares   1,740,658          
Issue common stock - Employee Stock Purchase Plan 304   304
Issue common stock - employee stock purchase plan, shares   203,480          
Issue common stock – conversion Series B Convertible Preferred Stock $ (186) 186  
Issue common stock - conversion Series B convertible preferred stock, shares (91,634) 91,634          
Investment in Veris Health Inc. subsidiary   6 6
Issue common stock – registered offerings, net $ 16 53,688   53,704
Issue common stock - registered offerings, net, shares   15,782,609          
Issue common stock upon partial conversions of Senior Secured Convertible Note $ 1 1,722   1,723
Conversions - senior secured convertible note, shares   667,668          
Balance - June 30, 2021 at Jun. 30, 2021 $ 2,499 $ 83 149,694 (109,325) (911) 42,040
Balance, shares at Jun. 30, 2021 1,185,685 82,576,816          
Balance - December 31, 2020 at Dec. 31, 2020 $ 2,537 $ 64 87,570 (88,275) (2,369) (473)
Balance, shares at Dec. 31, 2020 1,228,075 63,819,935          
Investment in Veris Health Inc. subsidiary           6  
Balance - June 30, 2021 at Dec. 31, 2021 $ 2,419 $ 86 198,071 (138,910) 17,752 79,418
Balance, shares at Dec. 31, 2021 1,113,919 86,367,845          
Balance - December 31, 2020 at Mar. 31, 2021 $ 2,587 $ 81 145,396 (97,778) (2,246) 48,040
Balance, shares at Mar. 31, 2021 1,241,438 81,424,744          
Series B Convertible Preferred Stock dividends declared $ 76 (76)  
Series B convertible preferred stock dividends declared, shares 25,046            
Vest - restricted stock awards
Vest - restricted stock awards, shares   150,000          
Exercise - stock options 51   51
Exercise - stock options, shares   40,832          
Stock-based compensation - PAVmed Inc. 2,622   2,622
Stock-based compensation - majority-owned subsidiary 52   2,528 2,580
Net Loss (11,471) (1,199) (12,670)
Issue common stock – exercise Series Z warrants $ 2 1,409   1,411
Issue common stock - exercise Series Z warrants, shares   880,441          
Issue common stock – conversion Series B Convertible Preferred Stock $ (164) 164  
Issue common stock - conversion Series B convertible preferred stock, shares (80,799) 80,799          
Investment in Veris Health Inc. subsidiary   6 6
Balance - June 30, 2021 at Jun. 30, 2021 $ 2,499 $ 83 149,694 (109,325) (911) 42,040
Balance, shares at Jun. 30, 2021 1,185,685 82,576,816          
Balance - December 31, 2020 at Dec. 31, 2021 $ 2,419 $ 86 198,071 (138,910) 17,752 79,418
Balance, shares at Dec. 31, 2021 1,113,919 86,367,845          
Series B Convertible Preferred Stock dividends declared $ 135 (135)
Series B convertible preferred stock dividends declared, shares 45,031            
Vest - restricted stock awards (1) (1)
Vest - restricted stock awards, shares   541,666          
Exercise - stock options $ 1 302 303
Exercise - stock options, shares   299,999          
Exercise - stock options of majority-owned subsidiary 688 688
Impact of subsidiary equity transactions 12 229 241
Stock-based compensation - PAVmed Inc. 2,726 2,726
Stock-based compensation - majority-owned subsidiary 7,094 7,094
Treasury stock (548) (548)
Treasury stock, shares   (380,544)          
Net Loss (42,397) (6,337) (48,734)
Issue common stock – exercise Series Z warrants
Issue common stock - exercise Series Z warrants, shares   5          
Issue common stock - Employee Stock Purchase Plan 217 217
Issue common stock - employee stock purchase plan, shares   194,240          
Investment in Veris Health Inc. subsidiary            
Balance - June 30, 2021 at Jun. 30, 2022 $ 2,554 $ 87 201,327 (181,442) (548) 19,426 41,404
Balance, shares at Jun. 30, 2022 1,158,950 87,023,211          
Balance - December 31, 2020 at Mar. 31, 2022 $ 2,486 $ 87 199,719 (155,849) (512) 18,802 64,733
Balance, shares at Mar. 31, 2022 1,136,210 86,911,646          
Series B Convertible Preferred Stock dividends declared $ 68 (68)
Series B convertible preferred stock dividends declared, shares 22,740            
Vest - restricted stock awards (1) (1)
Vest - restricted stock awards, shares   75,000          
Exercise - stock options 61 61
Exercise - stock options, shares   62,500          
Exercise - stock options of majority-owned subsidiary 501 501
Impact of subsidiary equity transactions 99 142 241
Stock-based compensation - PAVmed Inc. 1,449 1,449
Stock-based compensation - majority-owned subsidiary 3,557 3,557
Treasury stock (36) (36)
Treasury stock, shares   (25,935)          
Net Loss (25,525) (3,576) (29,101)
Balance - June 30, 2021 at Jun. 30, 2022 $ 2,554 $ 87 $ 201,327 $ (181,442) $ (548) $ 19,426 $ 41,404
Balance, shares at Jun. 30, 2022 1,158,950 87,023,211